XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance at Dec. 31, 2021 $ 137 $ 91,107   $ 117,626 $ (400)   $ 208,470
Beginning balance (in shares) at Dec. 31, 2021 13,669,772            
Net Income (Loss)       23,601     23,601
Other comprehensive income (loss)         (30,516)   (30,516)
Dividend declared on common stock       (2,799)     (2,799)
Exercise of stock options $ 3 3,051         3,054
Exercise of stock options (in shares) 325,649            
Restricted stock vesting (in shares) 16,613            
Share-based compensation   402         402
Ending balance at Sep. 30, 2022 $ 140 94,560   138,428 (30,916)   202,212
Ending balance (in shares) at Sep. 30, 2022 14,012,034            
Beginning balance at Jun. 30, 2022 $ 140 93,935   130,383 (16,928)   207,530
Beginning balance (in shares) at Jun. 30, 2022 13,968,053            
Net Income (Loss)       8,045     8,045
Other comprehensive income (loss)         (13,988)   (13,988)
Exercise of stock options   492         492
Exercise of stock options (in shares) 43,615            
Restricted stock vesting (in shares) 366            
Share-based compensation   133         133
Ending balance at Sep. 30, 2022 $ 140 94,560   138,428 (30,916)   202,212
Ending balance (in shares) at Sep. 30, 2022 14,012,034            
Beginning balance at Dec. 31, 2022 $ 141 94,726 $ (2,292) 146,630 (28,697) $ (2,292) 212,800
Beginning balance (in shares) at Dec. 31, 2022 14,043,801            
Net Income (Loss)       656     656
Other comprehensive income (loss)         11,727   11,727
Dividend declared on common stock       (3,108)     (3,108)
Exercise of stock options   320         320
Exercise of stock options (in shares) 27,375            
Restricted stock vesting (in shares) 9,037            
Share-based compensation   464         464
Ending balance at Sep. 30, 2023 $ 141 95,510   141,886 (16,970)   220,567
Ending balance (in shares) at Sep. 30, 2023 14,080,213            
Beginning balance at Jun. 30, 2023 $ 141 95,380   152,024 (28,575)   218,970
Beginning balance (in shares) at Jun. 30, 2023 14,079,847            
Net Income (Loss)       (10,137)     (10,137)
Other comprehensive income (loss)         11,605   11,605
Dividend declared on common stock       (1)     (1)
Restricted stock vesting (in shares) 366            
Share-based compensation   130         130
Ending balance at Sep. 30, 2023 $ 141 $ 95,510   $ 141,886 $ (16,970)   $ 220,567
Ending balance (in shares) at Sep. 30, 2023 14,080,213